Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients
Nicolas M. Van Mieghem, G. Michael Deeb, Lars Søndergaard, Eberhard Grube et autres
Importance: In patients with severe aortic valve stenosis at intermediate surgical risk, transcatheter aortic valve replacement (TAVR) with a self-expanding supra-annular valve was noninferior to surgery for all-cause mortality or disabling stroke at 2 years. Comparisons of longer-term clinical and hemodynamic outcomes …
nl, us, dk, de, ch, ie, ca (code pays fourni par la source)
195 citations
JAMA Cardiology